pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
AXSOME · news · pharmadog
← back to AXSOME
News mentioning AXSOME
15
stories
14d
The FDA’s 505(b)(2) pathway is an underestimated engine of value creation
biospace
Jun 12, 26
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
biopharma dive
Jun 4, 26
Otsuka showcases kidney drug data; Pfizer cuts an AI deal
biopharma dive
Jun 3, 26
Axsome pushes back generic entry for narcolepsy drug until 2040
endpoints
May 5, 26
STAT+: A new attack on AMA’s billing codes
stat
May 5, 26
STAT+: Are analysts too quick to gloss over Lilly’s liver case?
stat
May 5, 26
STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
stat
May 5, 26
STAT+: Johnson & Johnson advances IBD therapy, despite trial miss
stat
May 4, 26
STAT+: Pump the brakes on AI, buddy; and deposition deadlock
stat
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
STAT+: Biotech raises $42 million to run Huntington’s disease trial
stat
May 2, 26
Federal appeals court blocks mailing of abortion pill mifepristone
stat
May 1, 26
Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
biopharma dive
May 1, 26
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
endpoints
May 1, 26
STAT+: Axsome wins FDA nod for Alzheimer’s agitation
stat
